The FDA will now consider granting its regenerative medicine designations to experimental therapies even if they are on clinical hold, a shift in operating procedures that could help smaller biotechs developing cell and gene therapies …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844